Elsevier Inc.

SHERPA: Unknown

People

  1. Ponce
    Ponce
  2. Giralt
    Giralt
  3. Devlin
    Devlin
  4. Perales
    Perales
  5. Papadopoulos
    Papadopoulos
  6. Scaradavou
    Scaradavou
  7. Dahi
    Dahi
  8. Young
    Young
  9. Jakubowski
    Jakubowski
  10. Kernan
    Kernan

Groups

  1. Biostatistics Service (57)
  2. Bone Marrow Transplant (57)
  3. CTCR Scholars (57)
  4. Center for Hematologic Malignancies (57)
  5. Department of Medicine (57)
  6. Epidemiology and Biostatistics (57)
  7. Hematologic Malignancies, Division of (57)
  8. MSK Grad Students (57)
  9. Master of Science in Clinical and Translational Cancer Research (57)
  10. Survivorship Research (47)
Search Within
  1. "Juliet Barker"
  2. "Biostatistics Service"
  3. "MSK Grad Students"
Formats
  1. Meeting Abstract (42)
  2. Journal Article (15)
Groups
  1. Biostatistics Service (57)
  2. Bone Marrow Transplant (57)
  3. CTCR Scholars (57)
  4. Center for Hematologic Malignancies (57)
  5. Department of Medicine (57)
  6. Epidemiology and Biostatistics (57)

More Groups

People
  1. Juliet Barker (57)
  2. Doris Ponce (55)
  3. Sergio Giralt (54)
  4. Sean Devlin (52)
  5. Miguel-Angel Perales (44)
  6. Esperanza Papadopoulos (35)

More People

Years
  1. 2024 (2)
  2. 2022 (2)
  3. 2020 (4)
  4. 2019 (4)
  5. 2018 (3)
  6. 2017 (7)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (53)
  2. Transplantation and Cellular Therapy (4)

Results (57)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy
    Journal Article

    Infante, M. S.; Nemirovsky, D.; Devlin, S.; DeWolf, S.; Tamari, R.; Dahi, P. B.; Lee, Y. J.; Chung, D. J.; Politikos, I.; Barker, J.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Peri-transplant vitamin and micronutrient status in allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Rodich, L.; Adintori, P. A.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Gossman, Z.; Shike, M.; Barker, J. N.; Jakubowski, A. A.; Kernan, N. A.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Double unit cord blood transplantation compares favorably to T-cell depleted matched adult donor transplantation for the treatment of acute leukemia due to a robust protection against relapse
    Meeting Abstract

    Politikos, I.; Flynn, J.; Devlin, S. M.; Fingrut, W.; Maloy, M. A.; Naputo, K.; Chinapen, S.; Rodriguez, N. T.; Quach, S.; Dominguez, Y.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • The impact of individual co-morbidities in myeloablative ex vivo CD34+ selected allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Shouval, R.; Fein, J. A.; Devlin, S. M.; Maloy, M. A.; Castillo Flores, N.; Lin, R. J.; Politikos, I.; Sanchez, M.; Scordo, M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Don't let the HCT-CI fool you: Similar outcomes with myeloablative CD34+ selected allo-HCT compared to unmodified RIC allo-HCT in patients with AML or MDS and high comorbidity scores
    Meeting Abstract

    Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; Politikos, I.; Sanchez-Escamilla, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT)
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Skinner, K.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparison of double unit cord blood transplants (dCBT) with 8/8 HLA-allele matched related (MRD) or unrelated donor (MUD) T-cell depleted (TCD) transplants in adults with myeloid malignancies: Comparable progression-free survival (PFS)
    Meeting Abstract

    Politikos, I.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Naputo, K.; O'Reilly, R. J.; Scaradavou, A.; Castro-Malaspina, H.; Dahi, P. B.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Addition of tocilizumab to cyclosporine/ MMF for acute graft-vs-host disease (aGVHD) prophylaxis in adult double unit cord blood transplant (dCBT) recipients: Promising preliminary results of a phase II clinical trial
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Cho, C.; Giralt, S. A.; Gyurkocza, B.; Hanash, A. M.; Papadopoulos, E. B.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save